GLPGF:OTCMKTS
Lakefront Biotherapeutics NV
$31.95
0.00%
(0.00) 1D
Sep 23, 9:55:12 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLPGF...
Mkt. cap
1.94B
Avg. vol.
3.00
Volume
0.00
52-wk high
$34.00
52-wk low
$26.24
Beta
0.70
Shares outstanding
65.90M
No. of employees
196
Mkt. cap
1.94B
Avg. vol.
3.00
Volume
0.00
52-wk high
$34.00
52-wk low
$26.24
Beta
0.70
Shares outstanding
65.90M
No. of employees
196
News stories
From web sources and news partners
Simply Wall Street
·
43 minutes ago
Sat Out Gilead Sciences' Rally? Here Is What Holders Saw
ad-hoc-news.de
·
1 hour ago
Enlivex moves 1-for-13 to 1-for-16 vote for Enlivex stock
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com